ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Beaza79
|
22K |
7.9M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
22K
|
7.9M
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Beaza79
|
22K |
7.9M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
22K
|
7.9M
|
0
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Beaza79
|
22K |
7.9M |
5 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
22K
|
7.9M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Beaza79
|
81 |
23K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
81
|
23K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Beaza79
|
81 |
23K |
4 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
81
|
23K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Beaza79
|
132 |
33K |
5 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
132
|
33K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Beaza79
|
81 |
23K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
23K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Beaza79
|
81 |
23K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
81
|
23K
|
0
|
|
ASX - By Stock
|
HCH |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Beaza79
|
259 |
48K |
5 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
259
|
48K
|
5
|
|
ASX - By Stock
|
HCH |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Beaza79
|
259 |
48K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
259
|
48K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
72 |
21K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
72
|
21K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
72 |
21K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
21K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
100 |
28K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
100
|
28K
|
2
|
|
ASX - By Stock
|
HCH Mining |
Re:
$?Bill in a ? Life mine
|
|
Beaza79
|
27K |
6.3M |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
27K
|
6.3M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
100 |
28K |
12 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
100
|
28K
|
12
|
|
ASX - By Stock
|
HCH Mining |
Re:
$?Bill in a ? Life mine
|
|
Beaza79
|
27K |
6.3M |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
27K
|
6.3M
|
0
|
|
ASX - By Stock
|
HCH Mining |
Re:
$?Bill in a ? Life mine
|
|
Beaza79
|
27K |
6.3M |
3 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
27K
|
6.3M
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
72 |
21K |
7 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
21K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
72 |
21K |
6 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
72
|
21K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Beaza79
|
100 |
28K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
100
|
28K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Phase 2 AML Trial Successful Concludes
|
|
Beaza79
|
81 |
23K |
21 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
81
|
23K
|
21
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Beaza79
|
4.4K |
2.0M |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|
ASX - By Stock
|
HCH |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Beaza79
|
259 |
48K |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
259
|
48K
|
3
|
|
ASX - By Stock
|
HCH Mining |
Re:
$?Bill in a ? Life mine
|
|
Beaza79
|
27K |
6.3M |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
27K
|
6.3M
|
1
|
|
ASX - By Stock
|
HCH Mining |
Re:
$?Bill in a ? Life mine
|
|
Beaza79
|
27K |
6.3M |
3 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
27K
|
6.3M
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Beaza79
|
887 |
350K |
5 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
887
|
350K
|
5
|
|
ASX - By Stock
|
SIS |
Re:
Ann: Appendix 4C and Quarterly Activities Report
|
|
Beaza79
|
5 |
2.6K |
4 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
5
|
2.6K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
2 |
28/07/24 |
28/07/24 |
ASX - By Stock
|
139
|
41K
|
2
|
|
ASX - By Stock
|
HCH |
Re:
Ann: Notification regarding unquoted securities - HCH
|
|
Beaza79
|
7 |
1.3K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
7
|
1.3K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
Beaza79
|
2.3K |
792K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
2.3K
|
792K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
0 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
139
|
41K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
2 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
139
|
41K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
6 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
139
|
41K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Beaza79
|
307 |
94K |
1 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
307
|
94K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to Present at TechKnow July Conference
|
|
Beaza79
|
132 |
33K |
9 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
132
|
33K
|
9
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Beaza79
|
887 |
350K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
887
|
350K
|
3
|
|
ASX - By Stock
|
HCH Mining |
Re:
$?Bill in a ? Life mine
|
|
Beaza79
|
27K |
6.3M |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
27K
|
6.3M
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Beaza79
|
887 |
350K |
3 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
887
|
350K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Chimeric: Media Thread
|
|
Beaza79
|
887 |
350K |
0 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
887
|
350K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Beaza79
|
307 |
94K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
307
|
94K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
Beaza79
|
36 |
9.9K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
3 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
139
|
41K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Beaza79
|
307 |
94K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
307
|
94K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Beaza79
|
22K |
7.9M |
3 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
22K
|
7.9M
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
139
|
41K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Beaza79
|
307 |
94K |
0 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
307
|
94K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
Beaza79
|
36 |
9.9K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
139
|
41K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial
|
|
Beaza79
|
36 |
9.9K |
1 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
36
|
9.9K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
Beaza79
|
139 |
41K |
4 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
139
|
41K
|
4
|
|